Powder: -20°C for 3 years | In solvent: -80°C for 1 year
O-2050 is a high affinity cannabinoid CB 1 receptor antagonist with a K i of 2.5 nM. O-2050 inhibits cannabinoid CB 2 receptor with Ki of 0.2 nM. O-2050 decreased food intake in mice and caused locomotor stimulation in mice [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約8-10 週間 | ¥ 491,500 |
50 mg | 約8-10 週間 | ¥ 639,500 |
100 mg | 約8-10 週間 | ¥ 808,000 |
説明 | O-2050 is a high affinity cannabinoid CB 1 receptor antagonist with a K i of 2.5 nM. O-2050 inhibits cannabinoid CB 2 receptor with Ki of 0.2 nM. O-2050 decreased food intake in mice and caused locomotor stimulation in mice [1]. |
In vivo | O-2050, administered intraperitoneally at doses of 1, 3, 10, and 30 mg/kg with a 30-minute pretreatment, significantly reduces food intake in mice in a dose-dependent manner. Notably, doses of 10 and 30 mg/kg of O-2050 also significantly enhance locomotor activity [1]. |
分子量 | 417.56 |
分子式 | C23H31NO4S |
CAS No. | 1883545-42-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: <41.76mg/ml
Ethanol: <41.76mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
O-2050 1883545-42-3 Others O 2050 O2050 Inhibitor inhibitor inhibit